American Journal on Addictions

Article	Citations
AAAP's Annual Meeting and Scientific Symposium	44
Stand against stigma	36
AAAP 36th Annual Meeting & Scientific Symposium Save the Date	32
AAAP Stimulant Use Disorder PIP	28
Call for Special Issue 2024	28
Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada	27
A scoping review of sensory‐based interventions to address alcohol consumption	26
2024 Annual Meeting Posters	25
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	24
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada	22
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	21
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	17
Longitudinal pathway from low academic performance in adolescence to prescription drug misuse in adulthood: The mediating role of substance use and the moderating role of sex	16
Interpreting divergent mortality outcomes in veterans with substance use disorder and adverse social determinants of health	16
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	16
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	16
Gender differences in circumstances associated with cannabis use	15
Call for Special Issue Papers 2025	15
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances	15
Become a member of AAAP!	14
2025 AAAP Case Conference	14
Synthetic cannabinoid use and the acquired preparedness model	13
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia	12
Call for Review Papers 2024	12
Narcotics Anonymous members in recovery from methamphetamine use disorder	11

AM Registration Flyer	11
Tobacco use and impulsivity in people with mental illness: A systematic review	11
Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms	10
PCSS‐MOUD AND ORN: Find out more about AAAP's national grant initiatives	10
Correlates of optimism among patients in substance use disorder inpatient treatment	10
Cannabis cessation and neurocognitive recovery: Patterns, predictors, and clinical implications—a systematic review	10
AAAP MEMBERSHIP: Reap the benefits of belonging to AAAP	10
Call for Special Issue Papers 2024	9
Preconference On‐Demand availability	9
Call for Review Papers 2024	9
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?	9
Emotional regulation in Gaming Disorder: A systematic review	9
Issue Information ‐ Editorial Board	8
Issue Information ‐ ToC	8
Wanted: SPC Members: Join AAAP's Scientific Program Committee (SPC) and shape the future of the Academy	8
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study	8
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population	8
AAAP MEMBERSHIP: Reap the benefits of belonging to AAAP	7
AAAP AATT Preconference	7
AAAP Call for Abstracts	7
AAAP Podcast EP	7
Issue Information	7
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates	7
Call for Review Papers 2025	7
AJA Annual Meeting 2023	7
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study	7
Extended‐release buprenorphine in pregnancy	7
Stand Against Stigma	6
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications	6
Issue Information ‐ Editorial Board	6
SAVE THE DATE: Don't miss out on next year's Annual Meeting, held in Memphis, TN!	6
Issue Information ‐ ToC	6
Issue Information	6
Personality predicting relapse: A facet analysis of the NEO PI‐R	5
BREAKING NEWS: AAAP Earns a Spot in ACCME's Innovation Partner Circle!	5
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder	5
2023 Advanced Addiction Psychopharmacology Course	5
AAAP's Performance in practice activities	5
Health care service utilization and drug overdose death: A national nested case–control registry study	5
Psychedelic‐assisted therapy for substance use disorders: Between urgency and uncertainty	5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us	5
Call for Special Issue Papers 2025	5
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	5
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)	5
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States	4
Call for Special Issue 2023	4
Cannabis Use Disorders Performance in Practice	4
AAAP NEWSLETTER: What do your colleagues have to say about the latest updates in Addiction Psychiatry?	4
Call for Review Papers 2026	4
Call for Symposium Abstracts	4

Addiction specialists' attitudes toward psychedelics: A National Survey	4
Call for special issue 2023	4
SAVE THE DATE: Don't miss out on next year's Annual Meeting, held in Memphis, TN!	4
A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting	4
Shining a light on alcohol use disorder through the eyes of the patient: Improving recognition and management	4
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study	4
	4
Treating beyond the city limits: Building capacity in all communities	4
2023 Addictions and Their Treatment Course	4
AAAP 2024 Self‐Assessment Exam Now Available	3
AJA AM save the date 2023	3
	3
Save the Date ‐ Annual Meeting 2025	3
Gambling, tobacco use, and health among individuals in substance use disorder treatment	3
Trends in substance use disorder diagnoses among Veterans, 2009–2019	3
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem	3
Stand Against Stigma	3
AJA AM Save the Date 2023	3
Psychotherapy Webinar Series AJA	3
FREE WEBINAR: Master MI Techniques with Dr. Brian Borsari, September 10, 2025	3
Call for Review Papers 2026	3
Mini‐Symposia I	3
Association between experiencing gambling problems and adverse behavioral health outcomes among U.S. military service members, 2018	3
Issue Information ‐ Editorial Board	3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth	3
Become an AAAP Member	3
Medical Update	3
36th AAAP Annual Meeting and Scientific Symposium Recap	3
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort	2
Call for Review Papers 2026	2
Medication Management for Stimulant Use Disorder Webinar	2
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem	2
Opioid Recover Network ‐ ORN: Recruiting qualified consultants for the ORN	2
The mediating role of impulsivity in the relationship between childhood maltreatment and depression in methamphetamine patients	2
Paper sessions	2
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	2
Issue Information ‐ Editorial Board	2
2025 Call for Symposium Abstracts	2
Cannabis Use PIP Ad	2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	2
Addiction Psychiatry Advanced Psychotherapy Curriculum	2
	2
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series	2
Call for Review Papers 2023	2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study	2
Call for special issue 2023	2
Call for Special Issue Papers 2026	2
Addiction Psychiatry Advanced Psychotherapy Curriculum	1
Medical Update	1
2025 Combined Poster File	1
AJA Annual Meeting 2024	1
NEW BUNDLED COURSES: Save big on these bundled courses as you prepare for the boards	1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization	1
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	1
AJA Psychedelics	1
Mini‐Symposia II	1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	1
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 2024	1
Session name: Medical update	1
Call for special issue 2023	1
Third ventricle volume and psychometric alterations in patients with alcohol usage	1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder	1
NEW SELF ASSESSMENT EXAM: Get ready for the boards with this re‐vamped self‐assessment exam	1
Associations among social determinants of health and opioid use disorder and overdose: An umbrella review	1
Opioid use disorder in the active service: Implications for intervention	1
Program title youth substance use and addiction timely updates on a critical issue	1
Call for Special Issue Papers 2026	1
33rd AAAP Annual Meeting and Scientific Symposium Recap	1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?	1
Examining family member characteristics by treatment status of the relative with substance use problems	1
2024 Annual Meeting Posters	1
Nicotine use and patient‐directed discharge rate in psychiatric inpatients: A retrospective cohort	1
Symposium I	1
Daily cannabis use may cause cannabis‐induced hyperalgesia	1
Symposium III	1
Call for special issue 2023	1
Social media use, smoking expectancies, and nicotine experimentation in early adolescents: A prospective cohort study	1
A longitudinal study on the impact of Internet gaming disorder on self‐perceived health, academic performance, and social life of first‐year college students	1
Cannabis and the overdose crisis among US adolescents	1
AAAP Pre‐Conference On‐Demand Course ‐ AATT & AAP	1

Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	1
AAAP conference agenda	1
2023 Advanced Addiction Psychopharmacology Course	1
PCSS exchange AJA Ad	1
Film & Media Workshop	1
Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder	1
Issue Information	1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use	1
AAAP Membership	1
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review	1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	1
Conference Schedule	1
Promoter region variant C‐824T in the TH gene modulates the subjective effects of cocaine	1
Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine‐related substance use disorder symptoms	1
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019	0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial	0
Discrimination experiences and problematic alcohol and cannabis use in young adulthood	0
Issue Information	0
AAAP PIPS 2023	0
Serum brain‐derived neurotrophic factor in relation to craving and duration of abstinence in patients with heroin dependence—A case‐control study	0
Addiction Psychiatry Advanced Psychotherapy Session, September 11, 2024	0
Become a AAAP Member	0
Issue Information	0
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder	0
AAAP Travel Awards Open	0
Persisting high rates of mental health disorders in patients in opioid agonist treatment—Results from a 6‐year longitudinal study	0
Racial and ethnic differences in self‐reported barriers to substance use treatment among emergency department patients	0
Film & Media Workshop	0
Readability, linguistic complexity, and stigma in ChatGPT responses to opioid use disorder FAQs: A comparative analysis	0
Estimating the effects of prenatal cannabis exposure on birth outcomes	0
Call for Review Papers 2025	0
Psychotherapy Webinar Series AJA	0
Addictions & Their Treatment Virtual Course, Sep 13‐14, 2024 ‐ 50% Discount Preconference 50% Off 2023 Self Assessment Exam	0
An examination of cannabis use motives among couples with intimate partner violence and alcohol use disorder	0
FREE WEBINAR: Cultural Considerations in Tribal Behavioral Health Practice, December 10, 2025	0
2022 Self‐Assessment examination	0
AAAP Psychotherapy Curriculum Series	0
Medication treatment for alcohol use disorder in special populations	0
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)	0
	0
Become A AAAP Member!	0
Symposium II	0
Call for review papers 2023	0
AJA psychedelic Ad	0
CSAM‐SMCA 2022 Scientific conference and annual meeting	0
Conference Schedule	0
AAAP's Educational Offerings	0
Become a AAAP Member	0
Travel Award AJA	0
AAAP Performance and Practice (PIP) Resources	0
Absorption of naloxone in patients prescribed buprenorphine‐naloxone	0
AAAP Podcast	0
Call for review papers 2023	0
Response to commentary, from Bisol et al., on “Tobacco use and impulsivity in people with mental illness: A systematic review,” Praecht, A. et al. (2025). Am. J. Addict. 34–4: 383–403	0
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths	0
Registration Open Now: Virtual Courses on Addictions and Their Treatment (Sep 12–13, 2025) and Advanced Addiction Psychopharmacology (Sep 20–21, 2025)	0
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?	0
Motivational Interviewing Performance in Practice	0
AAAP podcast	0
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment	0
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience	0
NEW SELF ASSESSMENT EXAM: Get ready for the boards with this re‐vamped self‐assessment exam	0
Response to Costa et al.: Caution is warranted when comparing estimates from differently defined study samples	0
Imposter syndrome and college students' drinking behaviors: The roles of negative affect and coping motivated alcohol use	0
A complex psychosocial portrait of substance use disorders among Indigenous people in the United States: A scoping review	0
Call for Special Issue 2022	0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US	0
2023 Reviewer List (n = 223)	0
Double trouble ‐ Examining the co‐occurrence of compulsive sexual behavior disorder and gambling disorder among two American samples	0
Issue Information	0
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O	0
2024 Reviewer List	0
Levels of engagement among office‐based opioid treatment (OBOT) patients with concurrent methamphetamine use	0
Reasons for electronic cigarette use: Differences based on sex and young adult status	0
ORN Consultant Recruitment ‐ Join A National Public Health Alliance	0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder	0
AAAP_Call for Review papers‐2024	0
Issue Information	0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?	0
Call for Review Papers 2024	0
Provider–patient relationships and trauma among pregnant patients with opioid‐use disorder	0
Stand against stigma	0
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study	0
FREE Online Self‐Assessment Exam: ORN StUD Performance in Practice (PIP)	0
Medical marijuana access and prolonged opioid use among adolescents and young adults	0
Managing Opioid Use Disorder Care in the Era of Fentanyl	0
Issue Information	0
Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate	0
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial	0
Symposium IV	0
Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate	0
Differential mortality among US veterans: Social determinants of health, substance use disorder, and substance use treatment	0
Issue Information	0
Motivational Interviewing PIP	0
Issue Information	0